Delivery Order SPE2DB22D3301-SPE2DB24FY9CD

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,980.13 firm fixed-price delivery order contract is for the supply of 4,563,356,570 units of Heparin Sodium 5,000 Unit/0.5 mL 0.5 mL. The contract has an ultimate completion date of January 19, 2024 and was awarded on January 18, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $2,413.80 Firm Fixed Price Delivery Order is for the provision of 4,564,336,591 units of Heparin 2,000 unit/2 mL vials. This contract has no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with a value of $2,160.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order for Heparin 2ML 25S, a critical pharmaceutical product. This award falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for the company...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,433.52, is for the delivery of Heparin 1,000 unit/500 ml-NS 500 ml medical products. It is a firm fixed-price delivery order contract that runs through January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency awarded a $497.97 delivery order contract to Amerisourcebergen Drug Corp for the supply of 10,000 unit/10mL vials of heparin. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 18, 2023 under the firm fixed price contract awarded on September 15, 2023. The Defense Logistics Agency utilizes indefinite delivery/indefinite quantity contracts to support the medical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,451.94 firm fixed price delivery order is for the supply of HEPAGAM B VIALML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary contract...
This federal contract award, SPE2DX22D0049|SPE2D825FA1HS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,031.94 firm fixed-price delivery order is not set aside and has a completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,537.20 Firm Fixed Price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract, with a performance period through May 2024, is under Amerisourcebergen's existing Indefinite Delivery Contract...
The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The award, valued at $25,757.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of March 25, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $22,239.98, is a firm fixed price delivery order that will be performed through June 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9CD
    Delivery Order

This federal contract award, identified as SPE2DB22D3301|SPE2DB24FY9CD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,506.29 firm fixed-price delivery order is for the provision of 4,564,983,479 units of heparin sodium 5,000 unit/0.5 mL, with a completion date of June 25, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award was not set aside for any specific business type.

Generated 9/23/24, 10:02 AM